Litcius/Paper detail

Heterosubtypic Protection Induced by a Live Attenuated Influenza Virus Vaccine Expressing Galactose-α-1,3-Galactose Epitopes in Infected Cells

Li-Meng Yan, Sylvia P. N. Lau, Chek Meng Poh, Vera Chan, Michael C. W. Chan, Malik Peiris, Leo L. M. Poon

2020mBio14 citationsDOIOpen Access PDF

Abstract

Influenza A viruses have multiple HA subtypes that are antigenically diverse. Classical influenza virus vaccines are subtype specific, and they cannot induce satisfactory heterosubtypic immunity against multiple influenza virus subtypes. Here, we developed a live attenuated H1N1 influenza virus vaccine that allows the expression of α-Gal epitopes by infected cells. Anti-α-Gal antibody is naturally produced by humans. In the presence of this antibody, human cells infected with this experimental vaccine virus can enhance several antibody-mediated immune responses in vitro . Importantly, mice expressing anti-α-Gal antibody in vivo can be fully protected by this H1N1 vaccine against a lethal H5 or H3 virus challenge. Our work demonstrates a new strategy for using a single influenza virus strain to induce broadly cross-reactive immune responses against different influenza virus subtypes.

Topics & Concepts

VirologyEpitopeGalactoseInfluenza vaccineAttenuated vaccineVirusInfluenza A virusBiologyImmunologyMicrobiologyAntibodyVirulenceBiochemistryGeneInfluenza Virus Research StudiesImmune Response and InflammationEscherichia coli research studies
Heterosubtypic Protection Induced by a Live Attenuated Influenza Virus Vaccine Expressing Galactose-α-1,3-Galactose Epitopes in Infected Cells | Litcius